{"id":"https://openalex.org/W2152855878","doi":"https://doi.org/10.1128/aac.02572-13","title":"Comparative Microbiological Studies of Transcription Inhibitors Fidaxomicin and the Rifamycins in Clostridium difficile","display_name":"Comparative Microbiological Studies of Transcription Inhibitors Fidaxomicin and the Rifamycins in Clostridium difficile","publication_year":2014,"publication_date":"2014-02-19","ids":{"openalex":"https://openalex.org/W2152855878","doi":"https://doi.org/10.1128/aac.02572-13","mag":"2152855878","pmid":"https://pubmed.ncbi.nlm.nih.gov/24550338","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3993244"},"language":"en","primary_location":{"id":"doi:10.1128/aac.02572-13","doi":"https://doi.org/10.1128/aac.02572-13","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.02572-13","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3993244","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006964684","display_name":"Farah Babakhani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farah Babakhani","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., San Diego, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030380976","display_name":"Jaime Seddon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaime Seddon","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., San Diego, California, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113001519","display_name":"P.S. Sears","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela Sears","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., San Diego, California, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1014,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.87502165,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"58","issue":"5","first_page":"2934","last_page":"2937"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":1.0},{"id":"https://openalex.org/keywords/rifamycin","display_name":"rifamycin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/clostridioides-difficile","display_name":"Clostridium difficile","score":0.9990000128746033},{"id":"https://openalex.org/keywords/clostridium-difficile-associated-diarrhea","display_name":"Clostridium difficile-associated diarrhea","score":0.8659999966621399},{"id":"https://openalex.org/keywords/rna-polymerase-inhibition","display_name":"RNA polymerase inhibition","score":0.8820000290870667},{"id":"https://openalex.org/keywords/transcription-inhibitors","display_name":"transcription inhibitors","score":0.8429999947547913},{"id":"https://openalex.org/keywords/antibiotic-synergy","display_name":"antibiotic synergy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/rifamycin-resistance","display_name":"rifamycin resistance","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2781342628","wikidata":"https://www.wikidata.org/wiki/Q5446672","display_name":"Fidaxomicin","level":5,"score":0.893002986907959},{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.8255095481872559},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7274811267852783},{"id":"https://openalex.org/C2908643440","wikidata":"https://www.wikidata.org/wiki/Q132809","display_name":"Clostridiales","level":4,"score":0.44600382447242737},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44033199548721313},{"id":"https://openalex.org/C2908810495","wikidata":"https://www.wikidata.org/wiki/Q327663","display_name":"Clostridium Infections","level":4,"score":0.41463056206703186},{"id":"https://openalex.org/C2776607351","wikidata":"https://www.wikidata.org/wiki/Q592153","display_name":"Clostridiaceae","level":3,"score":0.3438246250152588},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.28830644488334656},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.23767197132110596},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13359776139259338},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.12795358896255493},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.10680839419364929},{"id":"https://openalex.org/C2777367657","wikidata":"https://www.wikidata.org/wiki/Q184651","display_name":"Toxin","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077732","descriptor_name":"Fidaxomicin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000617","descriptor_name":"Aminoglycosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012294","descriptor_name":"Rifamycins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.02572-13","doi":"https://doi.org/10.1128/aac.02572-13","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.02572-13","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3993244","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3993244","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:24550338","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24550338","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3993244","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3993244","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2419550889","display_name":"New Treatment for C. difficile-Associated Diarrhea","funder_award_id":"R44AI063692","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1559039796","https://openalex.org/W1684043645","https://openalex.org/W1988399731","https://openalex.org/W2003497105","https://openalex.org/W2044370864","https://openalex.org/W2098455823","https://openalex.org/W2102219089","https://openalex.org/W2102472050","https://openalex.org/W2112510426","https://openalex.org/W2113556993","https://openalex.org/W2114314510","https://openalex.org/W2119278807","https://openalex.org/W2119723188","https://openalex.org/W2123776003","https://openalex.org/W2133926562","https://openalex.org/W2135913675","https://openalex.org/W2138430214","https://openalex.org/W2139754977","https://openalex.org/W2154774987","https://openalex.org/W2155293017","https://openalex.org/W2156646748","https://openalex.org/W2163741559","https://openalex.org/W2165050668","https://openalex.org/W2169529718","https://openalex.org/W2170160838","https://openalex.org/W2170321757","https://openalex.org/W2170713114","https://openalex.org/W2743041357"],"related_works":["https://openalex.org/W4224286658","https://openalex.org/W4205519429","https://openalex.org/W2217917186","https://openalex.org/W2890021963","https://openalex.org/W4404108791","https://openalex.org/W4283577003","https://openalex.org/W2979591527","https://openalex.org/W2113287174","https://openalex.org/W2266322845","https://openalex.org/W2333195366"],"abstract_inverted_index":{"Fidaxomicin":[0],"(FDX)":[1],"is":[2],"a":[3,25,48],"narrow-spectrum":[4],"antibiotic":[5],"for":[6,51],"the":[7,18,52,69],"treatment":[8],"of":[9,28,33,54,71,73],"Clostridium":[10],"difficile-associated":[11],"diarrhea.":[12],"While":[13],"FDX":[14,23,42,74],"and":[15,58,75],"rifamycins":[16],"share":[17],"same":[19],"target":[20],"(RNA":[21],"polymerase),":[22],"exhibits":[24],"unique":[26],"mode":[27],"action":[29,72],"distinct":[30],"from":[31],"that":[32],"rifamycins.":[34,63,76],"In":[35],"comparative":[36],"microbiological":[37],"studies":[38],"with":[39,45,62],"C.":[40],"difficile,":[41],"interacted":[43],"synergistically":[44],"rifamycins,":[46,57],"demonstrated":[47],"lower":[49],"propensity":[50],"development":[53],"resistance":[55],"to":[56],"exhibited":[59],"no":[60],"cross-resistance":[61],"These":[64],"results":[65],"highlight":[66],"differences":[67],"in":[68],"mechanisms":[70]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}